Understanding how ribonucleases control gene expression
The control of gene expression by eukaryotic ribonucleases
This study is looking at how certain enzymes that break down RNA help control gene activity in cells, especially when they're under stress, which could lead to new discoveries about genetic disorders and cancer for people affected by these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11137663 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which ribonucleases, enzymes that degrade RNA, regulate gene expression in cells. It focuses on how these enzymes manage the quality of RNA and influence the production of proteins, particularly during stress conditions. The study employs advanced techniques like RNA sequencing to analyze the effects of splicing factors on gene expression and the role of specific ribonucleases linked to cancer. By understanding these processes, the research aims to uncover new insights into genetic disorders and cancer biology.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders or cancers that may be influenced by RNA processing and gene expression.
Not a fit: Patients with conditions unrelated to RNA processing or gene expression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating genetic disorders and cancers by targeting RNA processing mechanisms.
How similar studies have performed: Previous research has shown promising results in understanding RNA processing and its implications in various diseases, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Chanfreau, Guillaume F — University of California Los Angeles
- Study coordinator: Chanfreau, Guillaume F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.